Almarsson et al., 2011 - Google Patents
Pharmaceutical co-crystal compositionsAlmarsson et al., 2011
- Document ID
- 3586708428221784334
- Author
- Almarsson Ã
- Bourghol Hickey M
- Peterson M
- Zaworotko M
- Moulton B
- Rodriguez-Hornedo N
- Publication year
External Links
Snippet
A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde, ketone, thioketone, nitrate ester, phosphate ester, thiophosphate ester, ester …
- 239000013078 crystal 0 title abstract description 7
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1608339B8 (en) | Pharmaceutical co-crystal of celecoxib-nicotinamide | |
| WO2004078163A3 (en) | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen | |
| Corvino et al. | Trends in H2S-donors chemistry and their effects in cardiovascular diseases | |
| Arunachalam et al. | α-Bisabolol attenuates doxorubicin induced renal toxicity by modulating NF-κB/MAPK signaling and caspase-dependent apoptosis in rats | |
| CL2017003245A1 (en) | 1,4-substituted piperidine derivatives | |
| MX385720B (en) | NEW HYDROXY ACID DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| UY33746A (en) | TREATMENT METHOD THAT USES SELECTIVE INHIBITORS OF BCL-2 | |
| BR112013019792A2 (en) | semantic audio track mixer | |
| CO7180223A2 (en) | Herbicidal composition that has improved herbicidal activity | |
| BR112018002499A2 (en) | method of preparing a compound of formula (a) or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof, compound produced by the method and pharmaceutical composition | |
| BR112015021983A2 (en) | heterocyclic compounds and their uses | |
| CU24315B1 (en) | NEW DERIVATIVES OF 5- (2- {[3- (AMINOMETIL) -3,4-DIHYDROISOQUIN0-2 (1 H) IL] CARBONIL} PHENYL) -1 H-PIRROL-3-CARBOXAMIDE AS BCL-2 INHIBITORS AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| PH12015502425A1 (en) | Novel compounds for selective histone deacetylase inhibitors, and pharmeceutical composition comprising the same | |
| PH12016500225A1 (en) | Novel quinoline-substituted compound | |
| MX2017012062A (en) | Pharmaceutical tetracycline composition for dermatological use. | |
| Farhan | Insights on the role of polyphenols in combating cancer drug resistance | |
| NZ709986A (en) | Pharmaceutical compositions comprising nitroxyl donors | |
| BR112012031510A2 (en) | pharmaceutical composition comprising amide derivative or a pharmaceutically acceptable salt thereof | |
| BR112016028270A8 (en) | 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | |
| Iciek et al. | Reactive sulfur compounds in the fight against COVID-19 | |
| MY190361A (en) | 2-acylaminothiazole derivative or salt thereof | |
| EA201200616A1 (en) | DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL | |
| BR112016002339A2 (en) | COMPOUND, METHODS FOR SYNTHESIS OF A COMPOUND AND FOR CONTROL OF UNDESIRABLE PLANTS, AND, COMPOSITION OF HERBICIDES | |
| BR112015026840A2 (en) | compound, pharmaceutically acceptable salt, pharmaceutical composition, use of a compound, and method for preventing or treating hyperphosphatemia | |
| SG11201906361YA (en) | Hdac6 selective inhibitors, preparation method therefor, and application thereof |